1% Pimecrolimus Cream

DPT Laboratories

Revision date : 2015-04-29

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
GHS07
Health risk rating 1
Safety risk rating 1
Environmental risk rating 1

General Information

Revision date

2015-04-29

Product name

1% Pimecrolimus Cream

Product name

1% Pimecrolimus Cream

Identification on the label/Trade name

Elidel

Product Synonyms

(1R, 9S12S, 13R, 14S, 17R, 18E,21S,23S, 24R, 25S, 27R)-12[(1E)-2-{(1R,3R,4S)-4-chloro-3-methoxycyclohexyl}-1-methylvinyl]-17-ethyl-1,14-dihydroxy-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-aza- tricyclo[22.3.1.0]octacos-18-ene-2,3,10,16-tetraone

Chemical name

1% Pimecrolimus CreamMOLECULAR WEIGHT: 810.47

CAS No.

137071-32-0

1.2.1 Relevant identified uses

Atopic dermatitis cream

Icons in SDS

GHS07

Company Information

company name

DPT Laboratories

Section 2

SECTION 2: Hazards identification

OSHA EMERGENCY OVERVIEW CAUTION STATEMENT: WARNING - This is prescription medication for the treatment of mild to moderate atopic dermatitis. This material must be used in the manner directed by the prescribing physician. A licensed pharmacist may have additional information. Should any adverse reaction occur, immediately contact the nearest emergency room and/or your physician.

Precautionary statements

P264: Wash hands thoroughly after handling P270: Do not eat, drink or smoke when handling this product P302 + P352 If on skin Wash with plenty of soap and water P332 + P313: If skin irritation occurs, Get immediate medical advice/attention P362: Take off contaminated clothes and wash before re-use ROUTES OF ENTRY Primary Skin absorption, Secondary Inhalation, ingestion, eye contact TARGET ORGANS: Skin ACUTE EXPOSURE: Irritation, skin burning sensations, or pruritus SIGNS AND SYMPTOMS OF EXPOSURE: Skin Irritation CHRONIC EXPOSURE Malignancy (e.g. skin and lymphoma) although no causal relationships have been established. Continuous long-term use of topical calcineurin inhibitors should be avoided. MEDICAL CONDITIONS POTENTIALLY AGGRAVATED BY EXPOSURE: Immunosuppressed Patients, Pimecrolimus 1% cream is not recommended for children less than 2 years of age. Patients with malignant or pre-malignant skin conditions CARCINOGENICITY: Not listed/listed as carcinogen or potential carcinogen by NTP, IARC Monographs

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.